不安腿综合征的治疗方法 - gabapentinoids 或多巴胺激动剂?
Vladimira Vuletić1, Jarosław Sławek2
1Clinical Department of Neurology, Medical Faculty, University in Rijeka, Croatia.
Neurologia i neurochirurgia polska
|February 18, 2026
概括
新的指导方针建议将 gabapentinoids 和 IV 铁用于不安腿综合征 (RLS),将多巴胺激动剂转移到条件使用. 这两种药物类别都有潜在的副作用,需要仔细考虑RLS治疗.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 不安静腿综合征 (RLS) 的发病原因尚不清楚.
- 目前的RLS治疗包括多巴胺激动剂, gabapentinoids,阿片类药物和铁.
- 美国睡眠医学学会在2025年更新了RLS治疗指南.
研究的目的:
- 审查2025年更新的美国睡眠医学学会关于RLS治疗的指导方针.
- 讨论对多巴胺激动剂和 gabapentinoids 的建议的转变.
- 呈现临床视角,关于两类药物对RLS的持续效用.
主要方法:
- 审查2025年美国睡眠医学学会实践指南.
- 对RLS药物的疗效和副作用的临床数据的分析.
- 基于临床经验和现有证据的专家意见.
主要成果:
- gabapentinoids 和静脉注射铁性碳酸盐糖现在是第一线RLS治疗方法,并有"强烈的建议".
- 多巴胺激动剂因潜在的副作用如增强和冲动控制障碍而被重新归类为"有条件反对".
- 建议使用高剂量的 gabapentinoids,同时建议使用低剂量的多巴胺激动剂;在老年患者中,gabapentinoids可能具有较高的戒断率.
结论:
- 尽管指导方针发生了变化,但 gabapentinoids 和多巴胺激动剂对于 RLS 管理仍然具有价值.
- 选择药物需要仔细考虑个体患者的因素,并发症和潜在的副作用.
- 两种药物类别都没有完全没有风险,这突出了个性化RLS治疗策略的必要性.
相关概念视频
01:27Restless Leg Syndrome and Night Terrors
606
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
606
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.4K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.4K
01:28Classification of Skeletal Muscle Relaxants
3.2K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.2K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
633
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
633
01:29Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K